Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.

作者信息

Jose Powell, Tomson Charles, Skali Hicham, Rouleau Jean, Braunwald Eugene, Arnold J Malcolm, Cuddy Thomas, Sussex Bruce, Bernstein Victoria, Pfeffer Marc, Solomon Scott

出版信息

J Am Coll Cardiol. 2006 Apr 18;47(8):1725-7. doi: 10.1016/j.jacc.2006.01.047. Epub 2006 Mar 29.

DOI:10.1016/j.jacc.2006.01.047

PMID:16631015

Abstract

摘要

相似文献

Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction.

J Am Coll Cardiol. 2006 Apr 18;47(8):1725-7. doi: 10.1016/j.jacc.2006.01.047. Epub 2006 Mar 29.

Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂在心肌梗死、中风和死亡风险方面的比较：一项荟萃分析。

J Hypertens. 2008 Jul;26(7):1282-9. doi: 10.1097/HJH.0b013e328306ebe2.

[Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].[亚临床白蛋白尿、微量白蛋白尿和蛋白尿——公认的心血管风险标志物？]

Dtsch Med Wochenschr. 2006 Nov 24;131(47):2665-71. doi: 10.1055/s-2006-956273.

Re: Secondary medical prevention in patients with peripheral arterial disease.关于：外周动脉疾病患者的二级医学预防

Eur J Vasc Endovasc Surg. 2008 Jan;35(1):59-60. doi: 10.1016/j.ejvs.2007.07.006. Epub 2007 Aug 27.

Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.肾素 - 血管紧张素系统阻断与慢性肾脏病合并蛋白尿患者的心血管结局：一项荟萃分析。

Am Heart J. 2008 May;155(5):791-805. doi: 10.1016/j.ahj.2008.01.031.

Angiotensin receptor blockers: novel role in high-risk patients.血管紧张素受体阻滞剂：在高危患者中的新作用。

Cardiol Clin. 2008 Nov;26(4):507-26. doi: 10.1016/j.ccl.2008.07.001.

Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.丹麦因外周动脉疾病或心肌梗死住院患者的二级医疗预防。

Eur J Vasc Endovasc Surg. 2008 Jan;35(1):51-8. doi: 10.1016/j.ejvs.2007.08.008. Epub 2007 Oct 17.

[Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].[慢性糖尿病肾病的临床研究及有关肾病和心血管疾病风险预防的最新数据]

Nephrol Ther. 2006 May;2 Suppl 3:S193-6.

Angiotensin converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria.非糖尿病性肾病伴非肾病性蛋白尿患者的血管紧张素转换酶抑制治疗

Pediatr Nephrol. 2000 May;14(5):438.

Are elderly people with the HOPE criteria prescribed angiotensin-converting enzyme inhibitors?

J Renin Angiotensin Aldosterone Syst. 2004 Mar;5(1):26. doi: 10.3317/jraas.2004.003.

引用本文的文献

Drugs' development in acute heart failure: what went wrong?急性心力衰竭药物研发：错在哪里？

Heart Fail Rev. 2018 Sep;23(5):667-691. doi: 10.1007/s10741-018-9707-y.

Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: a 7-year follow-up study.肾功能障碍、左心室充盈受限模式与心力衰竭患者的死亡风险：一项 7 年随访研究。

BMC Nephrol. 2013 Dec 3;14:267. doi: 10.1186/1471-2369-14-267.

Inhibiting the renin-angiotensin system with ACE Inhibitors or ARBs after MI.心肌梗死后使用血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体拮抗剂抑制肾素-血管紧张素系统。

Curr Heart Fail Rep. 2007 Dec;4(4):190-7. doi: 10.1007/s11897-007-0012-7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验